Volume 68, Pages 18-34.e3 (March 2017) Optimizing the Diagnosis and Management of Dravet Syndrome: Recommendations From a North American Consensus Panel Elaine C. Wirrell, MD, Linda Laux, MD, Elizabeth Donner, MD, Nathalie Jette, MD, Kelly Knupp, MD, Mary Anne Meskis, Ian Miller, MD, Joseph Sullivan, MD, Michelle Welborn, Pharm D, Anne T. Berg, PhD Pediatric Neurology Volume 68, Pages 18-34.e3 (March 2017) DOI: 10.1016/j.pediatrneurol.2017.01.025 Copyright © 2017 Elsevier Inc. Terms and Conditions
Figure 1 Panel expertise. (The color version of this figure is available in the online edition.) Pediatric Neurology 2017 68, 18-34.e3DOI: (10.1016/j.pediatrneurol.2017.01.025) Copyright © 2017 Elsevier Inc. Terms and Conditions
Figure 2 Extent of personal experience in each area. (A) Physicians. (B) Family members/caregivers. AED, antiepileptic drug; EEG, electroencephalography; SUDEP, sudden unexpected death in epilepsy. (The color version of this figure is available in the online edition.) Pediatric Neurology 2017 68, 18-34.e3DOI: (10.1016/j.pediatrneurol.2017.01.025) Copyright © 2017 Elsevier Inc. Terms and Conditions
Figure 3 Treatment algorithm for Dravet syndrome. *Ketogenic diet is not suitable for all patients; its use is not required before moving to third-line therapies. aAgreed upon by moderate consensus. bAgreed upon by strong consensus. cStiripentol not approved for use in all jurisdictions. sz, seizures. Pediatric Neurology 2017 68, 18-34.e3DOI: (10.1016/j.pediatrneurol.2017.01.025) Copyright © 2017 Elsevier Inc. Terms and Conditions